Clinical TrialsSearch results
Number of results: 201
Other
- Phase II study of irinotecan and amrubicin for relapsed non-small-cell lung cancer
- Relapsed non-small-cell lung cancer
- Okayama Lung Cancer Study Group
- 2005-09-12
Other
- Phase II study of topotecan and amrubicin for metastatic or relapsed small-cell lung cancer
- Metastatic or relapsed small-cell lung cancer
- Okayama Lung Cancer Study Group
- 2005-09-12
Other
- Phase II study of topotecan and cisplatin for elderly small-cell lung cancer
- Elderly small-cell lung cancer
- Okayama Lung Cancer Study Group
- 2005-09-12
Other
- Randomized phase II trial of S-1 plus docetaxel combination versus single-agent docetaxel in platinum-pretreated patients with non-small-cell lung cancer
- platinum-pretreated patients with non-small-cell lung cancer
- Okayama Lung Cancer Study Group
- 2005-09-12
Other
- Randomized comparative study of cisplatin, docetaxel, and irinotecan versus cisplatin and docetaxel in patients with stage IIIB or stage IV non-small cell lung cancer (OLCSG 0403)
- Stage IIIB or Stage IV Non-Small Cell Lung Cancer
- Okayama Lung Cancer Study Group (OLCSG)
- 2005-09-13
Other
- Randomized, comparative clinical study of cisplatin and docetaxel combination chemotherapy and mitomycin, vindesine and cisplatin (MVP) combination chemotherapy with concurrent thoracic radiation therapy for locally advanced unresectable non-small-cell lung cancer (OLCSG0007)
- inoperable locally advanced non-small-cell lung cancer
- Okayama Lung Cancer Study Group (OLCSG)
- 2005-09-12
Other
- A prospective cohort study of peginterferon alpha-2a plus ribavirin treatment in patients with chronic hepatitis C.
- Chronic hepatitis C
- Okayama University Hospital
- 2008-02-29
Other
- An open-label, randomized, controlled trial comparing different dosing regimens with peginterferon alpha-2a plus ribavirin in patients with chronic hepatitis C.
- Chronic hepatitis C with serogroup 1 and high viral load (>= 100 KIU/mL).
- Okayama University Hospital
- 2008-02-29
Other
- Open-label, randomized, controlled study evaluating dose-escalation of peginterferon alpa-2b plus ribavirin in aged patients with chronic hepatitis C
- Chronic hepatitis C
- Okayama University Hospital
- 2014-10-01
Other
- Open-label, randomized, controlled study peginterferon alpa-2b plus dose-escalation of ribavirin in patients with chronic hepatitis C
- Chronic hepatitis C
- Okayama University Hospital
- 2014-10-01